18.92
price up icon1.34%   0.25
pre-market  Vorhandelsmarkt:  19.51   0.59   +3.12%
loading

Denali Therapeutics Inc Aktie (DNLI) Neueste Nachrichten

pulisher
May 05, 2026

Privium Fund Opens $5.07 Million Denali Stake Ahead of FDA Drug Approval - The Motley Fool

May 05, 2026
pulisher
May 05, 2026

MSN Money - MSN

May 05, 2026
pulisher
May 04, 2026

Assessing Denali Therapeutics (DNLI) Valuation After Takeda Ends DNL593 Partnership - Sahm

May 04, 2026
pulisher
May 04, 2026

Why Denali Therapeutics (DNLI) Is Down 8.2% After Takeda Exits DNL593 Collaboration And Returns Rights - Yahoo Finance

May 04, 2026
pulisher
May 03, 2026

DNLI gains 25.4% year to date: Should you buy, sell or hold the stock? - MSN

May 03, 2026
pulisher
May 03, 2026

D.A. Davidson & CO. Invests $1.77 Million in Denali Therapeutics Inc. $DNLI - MarketBeat

May 03, 2026
pulisher
May 03, 2026

Denali: The First Commercial Validation Of The Blood-Brain Barrier Platform - Seeking Alpha

May 03, 2026
pulisher
May 02, 2026

Is Takeda Pharmaceutical Company Limited (TAK) One of the Best Japanese Stocks Amid Restructuring Drive? - Yahoo Finance

May 02, 2026
pulisher
May 01, 2026

Precision Trading with Denali Therapeutics Inc. (DNLI) Risk Zones - Stock Traders Daily

May 01, 2026
pulisher
May 01, 2026

Denali Therapeutics Inc. $DNLI Shares Bought by Pictet Asset Management Holding SA - MarketBeat

May 01, 2026
pulisher
Apr 30, 2026

Denali Therapeutics Inc. (NASDAQ:DNLI) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Apr 30, 2026
pulisher
Apr 29, 2026

Denali Therapeutics (NASDAQ:DNLI) Trading Down 8.1%What's Next? - MarketBeat

Apr 29, 2026
pulisher
Apr 29, 2026

Denali Therapeutics Reclaims DNL593 Rights After Takeda Collaboration Ends - HarianBasis.co

Apr 29, 2026
pulisher
Apr 29, 2026

What Makes Denali Therapeutics (DNLI) One of the Best Biotech Stocks to Invest in - Yahoo Finance

Apr 29, 2026
pulisher
Apr 28, 2026

10 Best Biotech Stocks with Highest Upside Potential - Insider Monkey

Apr 28, 2026
pulisher
Apr 28, 2026

Denali gains on FDA approval of lead asset - MSN

Apr 28, 2026
pulisher
Apr 28, 2026

DNLI Stock Price, Quote & Chart | DENALI THERAPEUTICS INC (NASDAQ:DNLI) - ChartMill

Apr 28, 2026
pulisher
Apr 27, 2026

FDA clears Denali Therapeutics drug as first brain-penetrating biologic for rare disease - MSN

Apr 27, 2026
pulisher
Apr 27, 2026

Denali Therapeutics dips after pricing $200M equity offering - MSN

Apr 27, 2026
pulisher
Apr 26, 2026

B. Metzler seel. Sohn & Co. AG Makes New $1.84 Million Investment in Denali Therapeutics Inc. $DNLI - MarketBeat

Apr 26, 2026
pulisher
Apr 25, 2026

Denali Therapeutics (NASDAQ:DNLI) Stock Rating Lowered by Wall Street Zen - MarketBeat

Apr 25, 2026
pulisher
Apr 23, 2026

Bernstein Upgrades Takeda Pharmaceutical (TAK) to Outperform - Yahoo Finance Singapore

Apr 23, 2026
pulisher
Apr 22, 2026

Leerink Partners Cuts Denali Therapeutics (NASDAQ:DNLI) Price Target to $35.00 - MarketBeat

Apr 22, 2026
pulisher
Apr 22, 2026

Denali CEO’s ‘greatest professional moment’ arrives as rare disease drug launches - BioSpace

Apr 22, 2026
pulisher
Apr 21, 2026

Denali Therapeutics (DNLI) CMO restates 204,402-share insider stake in Form 3/A - Stock Titan

Apr 21, 2026
pulisher
Apr 21, 2026

Form DEFA14A Denali Therapeutics Inc. - StreetInsider

Apr 21, 2026
pulisher
Apr 21, 2026

[ARS] Denali Therapeutics Inc. SEC Filing - Stock Titan

Apr 21, 2026
pulisher
Apr 21, 2026

Denali Therapeutics (NASDAQ: DNLI) sets 2026 virtual meeting and pay vote - Stock Titan

Apr 21, 2026
pulisher
Apr 21, 2026

Wedbush Cuts Price Target on Denali Therapeutics to $25 From $30, Keeps Outperform Rating - marketscreener.com

Apr 21, 2026
pulisher
Apr 20, 2026

Denali Therapeutics (DNLI) CMO details 170,612-share equity stake in Form 3 - Stock Titan

Apr 20, 2026
pulisher
Apr 20, 2026

Targeted therapies dominate March’s five NME approvals - BioWorld News

Apr 20, 2026
pulisher
Apr 20, 2026

Denali (DNLI) Stock: Why Smart Money Likes It (Investor Interest) 2026-04-20Social Buy Zones - Cổng thông tin điện tử Tỉnh Sơn La

Apr 20, 2026
pulisher
Apr 20, 2026

Orsini Selected as the Exclusive Specialty Pharmacy and Home Infusion Partner for Denali Therapeutics' AVLAYAH™ (tividenofusp alfa-eknm) - BioSpace

Apr 20, 2026
pulisher
Apr 20, 2026

Technical Reactions to DNLI Trends in Macro Strategies - Stock Traders Daily

Apr 20, 2026
pulisher
Apr 18, 2026

DNLI Should I Buy - Intellectia AI

Apr 18, 2026
pulisher
Apr 18, 2026

Why Denali Therapeutics (DNLI) Is Up 7.4% After Regaining Full Rights To DNL593 Collaboration - Sahm

Apr 18, 2026
pulisher
Apr 17, 2026

DNLI Gains 25.4% Year to Date: Should You Buy, Sell or Hold the Stock? - TradingView

Apr 17, 2026
pulisher
Apr 16, 2026

Hunter Syndrome Market to Surpass USD 1.2 Billion by 2036 | 15+ Emerging Therapies and 10+ Companies Driving Innovation, analyses DelveInsight - Barchart

Apr 16, 2026
pulisher
Apr 16, 2026

DNLI.O Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Apr 16, 2026
pulisher
Apr 13, 2026

Retail Surge: Can Denali Therapeutics Inc withstand a market correction2026 Drop Watch & Low Risk Profit Maximizing Plans - baoquankhu1.vn

Apr 13, 2026
pulisher
Apr 13, 2026

Pullback Watch: Is Denali Therapeutics Inc stock suitable for long term investingQuarterly Trade Report & Smart Money Movement Tracker - baoquankhu1.vn

Apr 13, 2026
pulisher
Apr 13, 2026

Denali Therapeutics Inc. $DNLI Shares Acquired by Baillie Gifford & Co. - MarketBeat

Apr 13, 2026
pulisher
Apr 11, 2026

Assessing Denali Therapeutics (DNLI) Valuation After Recent Share Pullback And Pipeline Growth Expectations - Sahm

Apr 11, 2026
pulisher
Apr 11, 2026

Pullback Watch: Can Denali Therapeutics Inc withstand a market correctionMarket Activity Summary & Community Verified Swing Trade Signals - baoquankhu1.vn

Apr 11, 2026
pulisher
Apr 10, 2026

Retail Surge: What are analysts price targets for Denali Therapeutics IncPrice Action & Risk Controlled Swing Alerts - baoquankhu1.vn

Apr 10, 2026
pulisher
Apr 09, 2026

Trading the Move, Not the Narrative: (DNLI) Edition - Stock Traders Daily

Apr 09, 2026
pulisher
Apr 09, 2026

Q3 EPS Estimate for Denali Therapeutics Increased by Analyst - MarketBeat

Apr 09, 2026
pulisher
Apr 09, 2026

How AVLAYAH’s Accelerated Approval and Takeda Exit Will Impact Denali Therapeutics (DNLI) Investors - Sahm

Apr 09, 2026
$28.32
price down icon 0.14%
$50.44
price up icon 0.48%
$95.50
price down icon 3.88%
$139.44
price down icon 0.41%
$147.21
price down icon 0.47%
ONC ONC
$297.49
price up icon 0.12%
Kapitalisierung:     |  Volumen (24h):